Arena Pharma, Investors Strike $24M Deal In Diet Drug Suit
Arena Pharmaceuticals Inc. has reached a $24 million cash-and-stock deal with a proposed class of investors to settle its seven-year battle in California federal court over allegations the company lied to...To view the full article, register now.
Already a subscriber? Click here to view full article